- Home
- EDSA vs GBR Comparison
EDSA vs GBR Comparison
Compare EDSA & GBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- GBR
- Stock Information
- Founded
- EDSA 2015
- GBR 1978
- Country
- EDSA Canada
- GBR United States
- Employees
- EDSA N/A
- GBR N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- GBR Oil & Gas Production
- Sector
- EDSA Health Care
- GBR Energy
- Exchange
- EDSA Nasdaq
- GBR Nasdaq
- Market Cap
- EDSA 6.1M
- GBR 6.1M
- IPO Year
- EDSA N/A
- GBR N/A
- Fundamental
- Price
- EDSA $1.89
- GBR $1.14
- Analyst Decision
- EDSA Strong Buy
- GBR
- Analyst Count
- EDSA 1
- GBR 0
- Target Price
- EDSA $21.00
- GBR N/A
- AVG Volume (30 Days)
- EDSA 31.2K
- GBR 9.6K
- Earning Date
- EDSA 02-07-2025
- GBR 11-13-2024
- Dividend Yield
- EDSA N/A
- GBR N/A
- EPS Growth
- EDSA N/A
- GBR N/A
- EPS
- EDSA N/A
- GBR N/A
- Revenue
- EDSA N/A
- GBR $147,000.00
- Revenue This Year
- EDSA N/A
- GBR N/A
- Revenue Next Year
- EDSA N/A
- GBR N/A
- P/E Ratio
- EDSA N/A
- GBR N/A
- Revenue Growth
- EDSA N/A
- GBR N/A
- 52 Week Low
- EDSA $1.69
- GBR $0.95
- 52 Week High
- EDSA $5.99
- GBR $1.82
- Technical
- Relative Strength Index (RSI)
- EDSA 37.11
- GBR 38.51
- Support Level
- EDSA $1.73
- GBR $1.13
- Resistance Level
- EDSA $2.55
- GBR $1.25
- Average True Range (ATR)
- EDSA 0.18
- GBR 0.02
- MACD
- EDSA 0.03
- GBR -0.00
- Stochastic Oscillator
- EDSA 25.58
- GBR 0.00
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.